Dry Eye Disease

In this multicenter, phase 3 randomized-controlled trial, researchers evaluated the efficacy and safety of SHR8028, a water-free cyclosporine solution, 0.1%, compared with vehicle in patients with dry eye...

Researchers compared the signs and symptoms of dry eye disease between men and women, and postmenopausal and premenopausal women.

The FDA has approved generic forms of rosuvastatin and a new option for dry eye disease and has heard recommendations to approve a new psoriasis drug.